These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15702268)

  • 1. Clinical isolates of Nocardia brasiliensis from Japan exhibit variable susceptibility to the antibiotic imipenem.
    Kageyama A; Hoshino Y; Watanabe M; Yazawa K; Mikami Y
    Mycopathologia; 2004 Oct; 158(3):275-8. PubMed ID: 15702268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic].
    Yazawa K; Mikami Y; Otozai K; Uno J; Arai T
    Jpn J Antibiot; 1989 Nov; 42(11):2354-62. PubMed ID: 2695658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocardia cyriacigeorgica is a significant pathogen responsible for nocardiosis in Japan and Thailand.
    Kageyama A; Hoshino Y; Yazawa K; Poonwan N; Takeshita N; Maki S; Mikami Y
    Mycopathologia; 2005 Aug; 160(1):15-9. PubMed ID: 16160763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of Nocardia brasiliensis infection in Taiwan during 2002-2012-clinical studies and molecular typing of pathogen by gyrB and 16S gene sequencing.
    Chen KW; Lu CW; Huang TC; Lu CF; Liau YL; Lin JF; Li SY
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):74-8. PubMed ID: 23791388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
    Vera-Cabrera L; Campos-Rivera MP; Escalante-Fuentes WG; Pucci MJ; Ocampo-Candiani J; Welsh O
    Antimicrob Agents Chemother; 2010 May; 54(5):2191-3. PubMed ID: 20308390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of Nocardia species to newer antimicrobial agents.
    Berkey P; Moore D; Rolston K
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1078-9. PubMed ID: 3190193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
    Lai CC; Tan CK; Lin SH; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2009 Jul; 64(1):73-8. PubMed ID: 19398458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
    Vera-Cabrera L; Gonzalez E; Rendon A; Ocampo-Candiani J; Welsh O; Velazquez-Moreno VM; Choi SH; Molina-Torres C
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3170-2. PubMed ID: 16940121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
    Glupczynski Y; Berhin C; Janssens M; Wauters G
    Clin Microbiol Infect; 2006 Sep; 12(9):905-12. PubMed ID: 16882297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic evaluation of 18 Nocardia isolates from human clinical samples in Mexico.
    Sánchez-Herrera K; Sandoval H; Couble A; Mouniee D; Ramírez-Durán N; Uzcategui de Morillo M; Serrano JA; Bergeron E; Boiron P; Rodríguez-Nava V
    J Mycol Med; 2012 Mar; 22(1):1-7. PubMed ID: 23177807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.
    Hashemi-Shahraki A; Heidarieh P; Bostanabad SZ; Hashemzadeh M; Feizabadi MM; Schraufnagel D; Mirsaeidi M
    Sci Rep; 2015 Dec; 5():17862. PubMed ID: 26638771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A nationwide survey of antimicrobial susceptibilities of clinical isolates to antibiotics in Japan (1988-1990)].
    Igari J
    Jpn J Antibiot; 1993 Jun; 46(6):454-71. PubMed ID: 8360981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.
    Lavigne JP; Sotto A; Nicolas-Chanoine MH; Bouziges N; Pagès JM; Davin-Regli A
    Int J Antimicrob Agents; 2013 Feb; 41(2):130-6. PubMed ID: 23280442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibilities of clinical Desulfovibrio isolates.
    Lozniewski A; Labia R; Haristoy X; Mory F
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2933-5. PubMed ID: 11557495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
    Saionji K; Shitara S; Kobayashi I
    Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins.
    Yazawa K; Mikami Y; Uno J; Otozai K; Arai T
    J Antimicrob Chemother; 1989 Dec; 24(6):921-5. PubMed ID: 2621177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Cuccurullo S; Mikami Y; Farina C; Utili R
    Transpl Infect Dis; 2011 Aug; 13(4):335-43. PubMed ID: 21156012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
    Vera-Cabrera L; Gómez-Flores A; Escalante-Fuentes WG; Welsh O
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3629-30. PubMed ID: 11709356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiological and clinical features of nine cases with nocardial infections].
    Maki Y; Uchida Y; Monji N; Mochimaru T; Morokuma Y; Karashima T; Kiyosuke M; Fujise M; Eto F; Miyake N; Shimono N; Kayamori Y; Kang D
    Rinsho Byori; 2011 Mar; 59(3):213-8. PubMed ID: 21560401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.